NDC11 00093312901
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00093-3129-01 | 00093-3129 |
| 00093-3129-1 | 00093-3129 |
| 0093-3129-01 | 0093-3129 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Disopyramide Phosphate | DISOPYRAMIDE PHOSPHATE | Teva Pharmaceuticals USA, Inc. | 11a68e26-d2e4-48f6-ba0f-9bdd5778f25a | 2024-09-25 | Warnings, Adverse reactions | 0093-3129-01 0093-3129 00093312901 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.